Circulation, Vol 75, 156-162, Copyright © 1987 by American Heart Association
P Theroux, JG Latour, C Leger-Gauthier and J De Lara
Fibrinopeptide A, platelet factor 4, beta-thromboglobulin, thromboxane B2,
and 6-keto-prostaglandin F1 alpha were estimated by radioimmunoassay on
venous plasma samples taken within 48 hr of admission from 16 consecutive
patients with unstable angina and 15 patients with stable angina matched
for clinical variables. The ratio of circulating platelet aggregates,
platelet aggregation to increasing concentrations of ADP (0.455 to 1.82
micrograms/ml), and platelet thromboxane B2 production in vitro were also
tested. The two groups of patients were statistically similar in terms of
sex distribution, age, presence of risk factors, use of medication, extent
of coronary artery disease and history of previous myocardial infarction.
Mean plasma levels of fibrinopeptide A were 2.7 +/- 0.4 ng/ml (geometric
means +/- SEM, range 1.5 to 5.5) in patients with stable angina vs 5.5 +/-
1.8 ng/ml (range 2.4 to 32; p less than .001) in those with unstable
angina. In the latter group, after 6 to 8 days, fibrinopeptide A levels
decreased to 3.6 +/- 0.5 ng/ml (range 1.5 to 9.3; p less than .04 vs
admission). All other variables measured were statistically identical in
the two groups. We conclude that plasma fibrinopeptide A levels, as opposed
to platelet factors, discriminate between patients with unstable and stable
angina, indicating an activation of the coagulation system in unstable
angina.
ARTICLES
Fibrinopeptide A and platelet factor levels in unstable angina pectoris
This article has been cited by other articles:
![]() |
R. De Paulis, E. Cetrano, M. Moscarelli, G. Ando, F. Bertoldo, R. Scaffa, F. Tomai, and L. Chiariello Effects of ascending aorta replacement on aortic root dilatation Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 86 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hasumura, N. Aoki, K. Kawano, M. Homori, A. Maki, Y. Hioki, K. Ishikawa, and H. Yoshino Platelet-Dependent Thrombin Generation in Patients with Unstable Angina Pectoris Angiology, December 1, 2001; 52(12): 811 - 818. [Abstract] [PDF] |
||||
![]() |
H. Ogawa, H. Soejima, K. Takazoe, S. Miyamoto, I. Kajiwara, H. Shimomura, T. Sakamoto, M. Yoshimura, K. Kugiyama, M. Kimura, et al. Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina Angiology, March 1, 2001; 52(3): 167 - 174. [Abstract] [PDF] |
||||
![]() |
M. C. Minnema, R. J. G. Peters, R. de Winter, Y. P. T. Lubbers, S. Barzegar, K. A. Bauer, R. D. Rosenberg, C. E. Hack, and H. t. Cate Activation of Clotting Factors XI and IX in Patients With Acute Myocardial Infarction Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2489 - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Zhao, P. Theroux, S. M. Snapinn, and F. L. Sax Intracoronary Thrombus and Platelet Glycoprotein IIb/IIIa Receptor Blockade With Tirofiban in Unstable Angina or Non-Q-Wave Myocardial Infarction : Angiographic Results From the PRISM-PLUS Trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms) Circulation, October 12, 1999; 100(15): 1609 - 1615. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Moruzzi, S Sarzi-Braga, M Rossi, and M Contini Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes Heart, September 1, 1999; 82(3): 343 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Li, J.-K. Teng, W.-C. Tsai, L.-M. Tsai, L.-J. Lin, H.-R. Guo, and J.-H. Chen Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1543 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Linder, J. Oldgren, N. Egberg, L. Grip, G. Larson, A. Siegbahn, and L. Wallentin The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease Eur. Heart J., April 1, 1999; 20(7): 506 - 518. [Abstract] [PDF] |
||||
![]() |
A. Manten, R. J. de Winter, M. C. Minnema, H. ten Cate, J. G. Lijmer, R. Adams, R. J.G. Peters, and S. J.H. van Deventer Procoagulant and proinflammatory activity in acute coronary syndromes Cardiovasc Res, November 1, 1998; 40(2): 389 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xiao and P. Theroux Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor Circulation, January 27, 1998; 97(3): 251 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Golino, M. Ragni, P. Cirillo, D. D'Andrea, A. Scognamiglio, A. Ravera, C. Buono, M. Ezban, N. Corcione, F. Vigorito, et al. Antithrombotic Effects of Recombinant Human, Active Site–Blocked Factor VIIa in a Rabbit Model of Recurrent Arterial Thrombosis Circ. Res., January 23, 1998; 82(1): 39 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, J. Tanouchi, J. Kato, M. Nishino, K. Iwai, H. Tanahashi, M. Hori, Y. Yamada, T. Kamada, and T. Ito Prethrombotic State Due to Hypercoagulability in Patients with Permanent Transvenous Pacemakers Angiology, October 1, 1997; 48(10): 901 - 906. [Abstract] [PDF] |
||||
![]() |
S. P. Schulman, P. J. Goldschmidt-Clermont, E. J. Topol, R. M. Califf, F. I. Navetta, J. T. Willerson, N. C. Chandra, A. D. Guerci, J. J. Ferguson, R. A. Harrington, et al. Effects of Integrelin, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist, in Unstable Angina: A Randomized Multicenter Trial Circulation, November 1, 1996; 94(9): 2083 - 2089. [Abstract] [Full Text] |
||||
![]() |
J. D. Marmur, S. V. Thiruvikraman, B. S. Fyfe, A. Guha, S. K. Sharma, J. A. Ambrose, J. T. Fallon, Y. Nemerson, and M. B. Taubman Identification of Active Tissue Factor in Human Coronary Atheroma Circulation, September 15, 1996; 94(6): 1226 - 1232. [Abstract] [Full Text] |
||||
![]() |
I. Ott, F.-J. Neumann, M. Gawaz, M. Schmitt, and A. Schomig Increased Neutrophil-Platelet Adhesion in Patients With Unstable Angina Circulation, September 15, 1996; 94(6): 1239 - 1246. [Abstract] [Full Text] |
||||
![]() |
M. Cushman, B. M. Psaty, E. Macy, E. G. Bovill, E. S. Cornell, L. H. Kuller, and R. P. Tracy Correlates of Thrombin Markers in an Elderly Cohort Free of Clinical Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1163 - 1169. [Abstract] [Full Text] |
||||
![]() |
L. M. Biasucci, G. Liuzzo, G. Caligiuri, G. Quaranta, F. Andreotti, G. Sperti, W. van de Greef, A. G. Rebuzzi, C. Kluft, and A. Maseri Temporal Relation Between Ischemic Episodes and Activation of the Coagulation System in Unstable Angina Circulation, June 15, 1996; 93(12): 2121 - 2127. [Abstract] [Full Text] |
||||
![]() |
D. Ardissino, P. A. Merlini, G. Gamba, P. Barberis, G. Demicheli, S. Testa, E. Colombi, A. Poli, R. Fetiveau, and C. Montemartini Thrombin Activity and Early Outcome in Unstable Angina Pectoris Circulation, May 1, 1996; 93(9): 1634 - 1639. [Abstract] [Full Text] |
||||
![]() |
L. Grip, C. Hellekant, I. Herzfeld, K. Malmberg, B. Svane, A. Szamosi, M. Velander, and L. Ryden Coronary Angioplasty in Patients with Unstable Angina, with Special Reference to Preceding Treatment with Antithrombin III and Heparin Clinical and Applied Thrombosis/Hemostasis, April 1, 1996; 2(2): 107 - 115. [Abstract] [PDF] |
||||
![]() |
D. Pratico and G. A. FitzGerald Testosterone and Thromboxane : Of Muscles, Mice, and Men Circulation, June 1, 1995; 91(11): 2694 - 2698. [Full Text] |
||||
![]() |
H. M. Hoffmeister, M. Jur, H. P. Wendel, W. Heller, and L. Seipel Alterations of Coagulation and Fibrinolytic and Kallikrein-Kinin Systems in the Acute and Postacute Phases in Patients With Unstable Angina Pectoris Circulation, May 15, 1995; 91(10): 2520 - 2527. [Abstract] [Full Text] |
||||
![]() |
S. G. Thompson, J. Kienast, S. D.M. Pyke, F. Haverkate, J. C.W. van de Loo, and The European Concerted Action on Thrombosis and Di Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris N. Engl. J. Med., March 9, 1995; 332(10): 635 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Koenig, E. Ernst, and A. Matrai Blood Rheology Associated with Cardiovascular Risk Factors and Chronic Cardiovascular Diseases: Results of an Epidemiologic Cross-sectional Study Angiology, January 1, 1988; 39(11): 986 - 995. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |